tetracycline and bismuth-oxychloride

Tailoring energy band structure of bismuth oxychloride (BiOCl)-based photocatalysts by virtue of the metal and/or non-metal elements is one of the promising strategy to address environmental issues, especially plays a crucial role in water remediation. However, it still remains a great challenge to balance the light-harvesting and charge carriers separation. Herein, a feasible strategy was proposed for the simultaneous integration of energy-band modulation and surface hydroxylation to alleviate the as-mentioned contradiction and long-standing issues. By using a simple one-pot hydrothermal method, In-S-co-doped BiOCl photocatalyst coupling with surface hydroxylation (denoted as In/BOC-S-OH) was prepared by the simultaneous co-precipitation and ripening process and exhibited a good photocatalytic activity for removing tetracycline (TC) under visible light-irradiation than the counterparts of In-doped BiOCl (In/BOC), S-doped BiOCl (In/BOC-S) or surface -OH modification BiOCl (In/BOC-OH). Such satisfied photocatalytic efficiency benefits from the synergistic effect on the visible light capture, charge migration and separation associated with the introduction of intermediate energy levels and surface defect, respectively. Accompanying with the introduction of In and S hetero-atoms intercalation, both the potentials of valence and conduction bands were adjusted and the reduction of the bandgap could promote the capture of photons. Meanwhile, the powerful polarization effect associated with the non-uniform charge distribution could promote the special separation of carriers. More importantly, the surface defects induced by hydroxylation could act as traps for photogenerated electrons to stimulate the rapid separation of carriers, thereby causing the cleavage of antibiotics on the catalytic surface. This research offers a reliable strategy and promising scheme via effective solar energy conversion and charge carrier separation to advance photocatalytic wastewater remediation.

Topics: Anti-Bacterial Agents; Hydroxylation; Light; Oxidation-Reduction; Tetracycline

Safety-net hospitals, which have limited financial resources and care for disadvantaged populations, have lower performance on measures of patient experience than non-safety-net hospitals. In 2011, the Centers for Medicare & Medicaid Services Hospital Value-Based Purchasing (VBP) program began tying hospital payments to patient-reported experience scores, but whether implementation of this program narrowed differences in scores between safety-net and non-safety-net hospitals is unknown.. To evaluate whether the VBP program's implementation was associated with changes in measures of patient-reported experience at safety-net hospitals compared with non-safety-net hospitals between 2008 and 2019.. This cohort study evaluated 2266 US hospitals that participated in the VBP program between 2008 and 2019. Safety-net hospitals were defined as those in the highest quartile of the disproportionate share hospital index. Data were analyzed from December 2021 to February 2022.. The primary outcomes were the Hospital Consumer Assessment of Healthcare Providers and Systems global measures of patient-reported experience and satisfaction, including a patient's overall rating of a hospital and willingness to recommend a hospital. Secondary outcomes included the 7 other Hospital Consumer Assessment of Healthcare Providers and Systems measures encompassing communication ratings, clinical processes ratings, and hospital environment ratings. Piecewise linear mixed regression models were used to assess annual trends in performance on each patient experience measure by hospital safety-net status before (July 1, 2007-June 30, 2011) and after (July 1, 2011-June 30, 2019) implementation of the VBP program.. This cohort study of 2266 US hospitals found that the VBP program was not associated with improved patient experience at safety-net hospitals vs non-safety-net hospitals during an 8-year period. Policy makers may need to explore other strategies to address ongoing differences in patient experience and satisfaction, including additional support for safety-net hospitals.

Topics: Aged; Anti-Bacterial Agents; Benzene Derivatives; Bismuth; Carbon Dioxide; Catalysis; Cohort Studies; Environmental Pollutants; Flame Retardants; Gases; Greenhouse Gases; Hospitals; Humans; Iron; Light; Medicare; Methane; Organophosphates; Oxidation-Reduction; Patient Care; Phosphates; Polymers; Reproducibility of Results; Tetracycline; Titanium; Ultraviolet Rays; United States; Value-Based Purchasing; Waste Disposal Facilities; Water Pollutants, Chemical

A high-efficiency hollow BiOCl@CeO

Topics: Anti-Bacterial Agents; Bismuth; Catalysis; Cerium; Environmental Restoration and Remediation; Microspheres; Oxidation-Reduction; Persistent Organic Pollutants; Tetracycline